Hepatic fibrosis is a foreshadowing of future adverse events like liver cirrhosis, liver failure, and cancer. Hepatic stellate cell activation is the main event of liver fibrosis, which results in excessive extracellular matrix deposition and hepatic parenchyma's disintegration. Several biochemical and molecular assays have been introduced for in vitro study of the hepatic fibrosis progression. However, they do not forecast real-time events happening to the in vitro models. Trans-epithelial electrical resistance (TEER) is used in cell culture science to measure cell monolayer barrier integrity. Herein, we explored TEER measurement's utility for monitoring fibrosis development in a dynamic cell culture microphysiological system. Immortal HepG2 cells and fibroblasts were co-cultured, and transforming growth factor β1 (TGF-β1) was used as a fibrosis stimulus to create a liver fibrosis-on-chip model. A glass chip-based embedded TEER and reactive oxygen species (ROS) sensors were employed to gauge the effect of TGF-β1 within the microphysiological system, which promotes a positive feedback response in fibrosis development. Furthermore, albumin, Urea, CYP450 measurements, and immunofluorescent microscopy were performed to correlate the following data with embedded sensors responses. We found that chip embedded electrochemical sensors could be used as a potential substitute for conventional end-point assays for studying fibrosis in microphysiological systems.

No abstract

Sensing devices have shown a tremendous potential for monitoring state of the art organ chip devices. However, challenges like miniaturization while maintaining the higher performance, longer operating times for continual...

With the recent global outbreaks of infectious diseases such as coronavirus disease 2019, developing a detection system capable of quickly and accurately diagnosing diseases on‐site has become a pressing need. The ability to diagnose patients in the field is crucial for the prompt isolation and treatment of infected individuals and the prevention of the spread of the disease. Our research group has recently developed a surface‐enhanced Raman scattering optofluidic system that enables rapid and accurate point‐of‐care diagnostics. This account will introduce the principle and configuration of the fluidic devices, such as lateral flow assay strips or microfluidic channels, and the portable Raman spectrometer. We will also highlight the challenges that must be addressed for using this system in clinical settings. Rapid and accurate diagnosis is critical for effective disease management and control, and developing this system can significantly improve our ability to respond to outbreaks of infectious diseases.